Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

[Image: see text] Despite advances in breast cancer treatment, it remains the leading cause of cancer-related death in women worldwide. In this context, microRNAs have emerged as potential therapeutic targets but still present some limitations for in vivo applications. Particularly, miR-200c-3p is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido-Cano, Iris, Adam-Artigues, Anna, Lameirinhas, Ana, Blandez, Juan F., Candela-Noguera, Vicente, Lluch, Ana, Bermejo, Begoña, Sancenón, Felix, Cejalvo, Juan Miguel, Martínez-Máñez, Ramón, Eroles, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436244/
https://www.ncbi.nlm.nih.gov/pubmed/37549382
http://dx.doi.org/10.1021/acsami.3c07541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436244/
https://www.ncbi.nlm.nih.gov/pubmed/37549382
http://dx.doi.org/10.1021/acsami.3c07541

Ejemplares similares